REPORTS

Let’s Pullulate and Expand Your Business

RNA Vaccines Market - Global Professional Analysis and Forecast to 2026

Feb 25, 2020  |  187 PAGES  |  REPORT CODE: CMM268606
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide RNA Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.1% during the forecast period.

This report presents the market size and development trends by detailing the RNA Vaccines market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the RNA Vaccines market will be shown in this report. In short, this report will comprehensively reveal the characteristics of RNA Vaccines industry and will help you to build a panoramic view of the industrial development.

RNA Vaccines Market, By Type:

  • Individualized Cancer Treatment MRNA Vaccine

  • Infectious Disease Treatment MRNA Vaccine

  • Infection Prevention MRNA Vaccine

RNA Vaccines Market, By Application:

  • Infectious Disease

  • Cancer

  • Other

Some of the leading players are as follows:

  • Ethris

  • BioNTech

  • Translate Bio

  • Moderna Therapeutics

  • Sangamo Therapeutics

  • In-Cell-Art

  • CureVac

  • eTheRNA

  • Argos Therapeutics

  • Tiba Biotechnology

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 RNA Vaccines Market: Technology Type Analysis

  • 4.1 RNA Vaccines Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 RNA Vaccines Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Individualized Cancer Treatment MRNA Vaccine

    • 4.3.2 Infectious Disease Treatment MRNA Vaccine

    • 4.3.3 Infection Prevention MRNA Vaccine

5 RNA Vaccines Market: Product Analysis

  • 5.1 RNA Vaccines Product Market Share Analysis, 2018 & 2026

  • 5.2 RNA Vaccines Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 RNA Vaccines Market: Application Analysis

  • 6.1 RNA Vaccines Application Market Share Analysis, 2018 & 2026

  • 6.2 RNA Vaccines Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Infectious Disease

    • 6.3.2 Cancer

    • 6.3.3 Other

7 RNA Vaccines Market: Regional Analysis

  • 7.1 RNA Vaccines Regional Market Share Analysis, 2018 & 2026

  • 7.2 RNA Vaccines Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Ethris

    • 9.1.1 Ethris Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 BioNTech

    • 9.2.1 BioNTech Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Translate Bio

    • 9.3.1 Translate Bio Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Moderna Therapeutics

    • 9.4.1 Moderna Therapeutics Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Sangamo Therapeutics

    • 9.5.1 Sangamo Therapeutics Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 In-Cell-Art

    • 9.6.1 In-Cell-Art Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 CureVac

    • 9.7.1 CureVac Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 eTheRNA

    • 9.8.1 eTheRNA Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Argos Therapeutics

    • 9.9.1 Argos Therapeutics Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Tiba Biotechnology

    • 9.10.1 Tiba Biotechnology Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

 

The List of Tables and Figures (Totals 74 Figures and 126 Tables)

  • Figure Individualized Cancer Treatment MRNA Vaccine RNA Vaccines market, 2015 - 2026 (USD Million)

  • Figure Infectious Disease Treatment MRNA Vaccine RNA Vaccines market, 2015 - 2026 (USD Million)

  • Figure Infection Prevention MRNA Vaccine RNA Vaccines market, 2015 - 2026 (USD Million)

  • Figure Infectious Disease market, 2015 - 2026 (USD Million)

  • Figure Cancer market, 2015 - 2026 (USD Million)

  • Figure Other market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America RNA Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table North America RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table North America RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table North America RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table U.S. RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table U.S. RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Canada RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Canada RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Europe RNA Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Europe RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Europe RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Europe RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table U.K. RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table U.K. RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Germany RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Germany RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table France RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table France RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Italy RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Italy RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Spain RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Spain RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific RNA Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table China RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table China RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Japan RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Japan RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table India RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table India RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Latin America RNA Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Latin America RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Latin America RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Latin America RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Brazil RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Brazil RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Mexico RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Mexico RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Argentina RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Argentina RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table MEA RNA Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table MEA RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table MEA RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table MEA RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table South Africa RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table South Africa RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria RNA Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria RNA Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria RNA Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Ethris Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BioNTech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Translate Bio Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Moderna Therapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sangamo Therapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table In-Cell-Art Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table CureVac Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table eTheRNA Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Argos Therapeutics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Tiba Biotechnology Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top